3ttz
From Proteopedia
(Difference between revisions)
m (Protected "3ttz" [edit=sysop:move=sysop]) |
|||
| Line 1: | Line 1: | ||
| - | + | [[Image:3ttz.jpg|left|200px]] | |
| - | The | + | <!-- |
| + | The line below this paragraph, containing "STRUCTURE_3ttz", creates the "Structure Box" on the page. | ||
| + | You may change the PDB parameter (which sets the PDB file loaded into the applet) | ||
| + | or the SCENE parameter (which sets the initial scene displayed when the page is loaded), | ||
| + | or leave the SCENE parameter empty for the default display. | ||
| + | --> | ||
| + | {{STRUCTURE_3ttz| PDB=3ttz | SCENE= }} | ||
| - | + | ===Crystal structure of a topoisomerase ATPase inhibitor=== | |
| - | + | ||
| + | <!-- | ||
| + | The line below this paragraph, {{ABSTRACT_PUBMED_22041057}}, adds the Publication Abstract to the page | ||
| + | (as it appears on PubMed at http://www.pubmed.gov), where 22041057 is the PubMed ID number. | ||
| + | --> | ||
| + | {{ABSTRACT_PUBMED_22041057}} | ||
| + | |||
| + | ==About this Structure== | ||
| + | [[3ttz]] is a 2 chain structure with sequence from [http://en.wikipedia.org/wiki/Staphylococcus_aureus Staphylococcus aureus]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=3TTZ OCA]. | ||
| + | |||
| + | ==Reference== | ||
| + | <ref group="xtra">PMID:022041057</ref><references group="xtra"/> | ||
| + | [[Category: Staphylococcus aureus]] | ||
| + | [[Category: Boriack-Sjodin, P A.]] | ||
| + | [[Category: Eakin, A E.]] | ||
| + | [[Category: Read, J.]] | ||
| + | [[Category: Sherer, B A.]] | ||
| + | [[Category: Antimicrobial]] | ||
| + | [[Category: Atp-binding]] | ||
| + | [[Category: Isomerase-isomerase inhibitor complex]] | ||
| + | [[Category: Protein-inhibitor complex]] | ||
| + | [[Category: Structure-based drug design]] | ||
Revision as of 12:15, 16 November 2011
Crystal structure of a topoisomerase ATPase inhibitor
Template:ABSTRACT PUBMED 22041057
About this Structure
3ttz is a 2 chain structure with sequence from Staphylococcus aureus. Full crystallographic information is available from OCA.
Reference
- Sherer BA, Hull K, Green O, Basarab G, Hauck S, Hill P, Loch JT 3rd, Mullen G, Bist S, Bryant J, Boriack-Sjodin A, Read J, Degrace N, Uria-Nickelsen M, Illingworth RN, Eakin AE. Pyrrolamide DNA gyrase inhibitors: Optimization of antibacterial activity and efficacy. Bioorg Med Chem Lett. 2011 Oct 12. PMID:22041057 doi:10.1016/j.bmcl.2011.10.010
